Explore how SBTi’s Net-Zero Standard V2.0 changes the rules for renewable energy reporting and how technology and advisory can support.
SBTi V2.0 enforces stricter corporate climate rules. Discover the critical decisions your team should make before February 1, 2027.
Watch a practical session exploring how biomethane can help tackle both your scope 1 and scope 3 decarbonisation efforts.
Watch a practical session exploring how the pharmaceutical industry can accelerate decarbonisation that matters most through innovative clean energy strategies.
Learn why pharma companies should rely on biomethane as a scalable, credible, and readily available low-carbon solution to address their scope 1 footprint.
As businesses work to address residual emissions, biochar has emerged as a key CDR solution.
